Related Experiment Videos
Insights into the mitochondrial signaling pathway: what lessons for chemotherapy?
Catherine Brenner1, Morgane Le Bras, Guido Kroemer
1CNRS UPRESA 8087, Université de Versailles/St Quentin, LGBC Buffon, 45 Avenue des Etats-Unis, 78035 Versailles, France. cbrenner@genetique.uvsq.fr
Abstract:
Mitochondria are potent integrators/coordinators of apoptosis signaling pathways. Indeed, under physiological conditions, the initiation of apoptosis leads to the accumulation of second messengers that converge on mitochondria. In response, these organelles undergo a membrane permeabilization, presumably due to the opening of protein channels, culminating in the release of proapoptotic proteins into the cytosol. Under pathological conditions, a failure of mitochondrial membrane permeabilization (MMP) can result in an inhibition of apoptosis and enhanced resistance to chemotherapy. Several non-mutually exclusive mechanisms may account for a defect in the execution or regulation of MMP. These include (i) alterations in gene transcription, (ii) gene mutations resulting in protein inactivation, and (iii) defects of intracellular localization. This may concern structural proteins of the permeability transition pore complex, as well as MMP regulatory proteins, such as Bax/Bcl-2 family members, p53, and cyclophilin D. Analysis of these mechanisms should improve our understanding of the basic function of mitochondria in apoptosis and help elaborate new strategies to correct MMP failure from a therapeutic perspective.
Insights
Mitochondrial membrane permeabilization (MMP) is crucial for apoptosis. Failures in MMP can inhibit apoptosis, leading to chemotherapy resistance, and may stem from genetic or localization defects.
Area of Science:
- Cell Biology
- Biochemistry
- Molecular Biology
Background:
- Mitochondria integrate apoptosis signaling pathways.
- Apoptosis initiation triggers second messenger accumulation, converging on mitochondria.
- Mitochondrial membrane permeabilization (MMP) releases proapoptotic proteins into the cytosol.
Purpose of the Study:
- To investigate the mechanisms underlying impaired mitochondrial membrane permeabilization (MMP) in pathological conditions.
- To understand the role of MMP failure in apoptosis inhibition and chemotherapy resistance.
- To identify potential therapeutic strategies targeting MMP defects.
Main Methods:
- Analysis of gene transcription alterations affecting MMP.
- Investigation of gene mutations leading to protein inactivation in apoptosis pathways.
- Examination of intracellular localization defects of MMP-related proteins.
Main Results:
- MMP failure can result from altered gene transcription, inactivating mutations, or incorrect protein localization.
- Defects may involve structural proteins of the permeability transition pore complex.
- Regulatory proteins like Bax/Bcl-2 family, p53, and cyclophilin D are implicated.
Conclusions:
- Understanding MMP mechanisms is key to comprehending mitochondrial function in apoptosis.
- Therapeutic strategies can be developed to correct MMP failure.
- Targeting MMP defects offers a promising avenue for overcoming chemotherapy resistance.